Karus raises $7.6M in series B

Karus Therapeutics Ltd. (Chilworth, U.K.) raised $7.6 million in a first tranche of a series B round led by new investors SV Life Science; New Leaf Ventures; Novo A/S; and International Biotechnology Trust. Existing investors IP Group and angel investors also participated. New Leaf Ventures' Srinivas Akkaraju, SV Life Science's Graham Boulnois; Novo A/S's Martin Edwards; and IP Group's Sam Williams joined the board. ...